A Phase II Study of Non-Myeloablative Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Antithymocyte Globulin (ATG) In Patients With Cutaneous T Cell Lymphoma.
Phase of Trial: Phase II
Latest Information Update: 14 Jul 2016
At a glance
- Drugs Antithymocyte globulin (Primary) ; Ciclosporin; Ciclosporin
- Indications Graft-versus-host disease; Mycosis fungoides; Sezary syndrome
- Focus Therapeutic Use
- 11 Oct 2011 Planned End Date changed from 1 Sep 2011 to 1 Dec 2022 as reported by ClinicalTrials.gov.
- 03 Jun 2009 New trial record.